All In Biotech

Drug Trial Radar · NCT07532603

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Lichen Planopilaris

Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 342 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

342

Planned (sponsor's estimate)

Start

Mar 19, 2026

Primary completion

Dec 31, 2028

Study completion Jul 31, 2029

Sponsor

Lead sponsor
Priovant Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Apr 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris

Conditions

  • Lichen Planopilaris

Interventions

  • Oral BrepocitinibDrug

    Oral

  • PlaceboDrug

    Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants achieving IGA score 0/1 and ≥ 2-step reduction from baseline at Week 24Time frame: Week 24

Locations

61 sites in 4 countries. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Birmingham, Alabama · Recruiting

  • Clinical Trial Site

    Phoenix, Arizona · Recruiting

  • Clinical Trial Site

    Scottsdale, Arizona · Recruiting

  • Clinical Trial Site

    Irvine, California · Recruiting

  • Clinical Trial Site

    Oakland, California · Recruiting

  • Clinical Trial Site

    Sacramento, California · Recruiting

  • Clinical Trial Site

    San Francisco, California · Recruiting

  • Clinical Trial Site

    Denver, Colorado · Recruiting

  • Clinical Trial Site

    Farmington, Connecticut · Recruiting

  • Clinical Trial Site

    New Haven, Connecticut · Recruiting

  • Clinical Trial Site

    Miami, Florida · Recruiting

  • Clinical Trial Site

    Chicago, Illinois · Recruiting

  • Clinical Trial Site

    Skokie, Illinois · Recruiting

  • Clinical Trial Site

    Clarksville, Indiana · Recruiting

  • Clinical Trial Site

    Indianapolis, Indiana · Recruiting

  • Clinical Trial Site

    Leawood, Kansas · Recruiting

  • Clinical Trial Site

    Louisville, Kentucky · Recruiting

  • Clinical Trial Site

    Boston, Massachusetts · Recruiting

  • Clinical Trial Site

    Burlington, Massachusetts · Recruiting

  • Clinical Trial Site

    Ann Arbor, Michigan · Recruiting

  • Clinical Trial Site

    Ann Arbor, Michigan · Recruiting

  • Clinical Trial Site

    Medina, Minnesota · Recruiting

  • Clinical Trial Site

    Minneapolis, Minnesota · Recruiting

  • Clinical Trial Site

    Kansas City, Missouri · Recruiting

  • Clinical Trial Site

    Lee's Summit, Missouri · Recruiting

  • Clinical Trial Site

    Lebanon, New Hampshire · Recruiting

  • Clinical Trial Site

    New Hyde Park, New York · Recruiting

  • Clinical Trial Site

    New York, New York · Recruiting

  • Clinical Trial Site

    Durham, North Carolina · Recruiting

  • Clinical Trial Site

    Cleveland, Ohio · Recruiting

  • Clinical Trial Site

    Columbus, Ohio · Recruiting

  • Clinical Trial Site

    Medina, Ohio · Recruiting

  • Clinical Trial Site

    Portland, Oregon · Recruiting

  • Clinical Trial Site

    Philadelphia, Pennsylvania · Recruiting

  • Clinical Trial Site

    Charleston, South Carolina · Recruiting

  • Clinical Trial Site

    Murfreesboro, Tennessee · Recruiting

  • Clinical Trial Site

    Smyrna, Tennessee · Recruiting

  • Clinical Trial Site

    Austin, Texas · Recruiting

  • Clinical Trial Site

    Austin, Texas · Recruiting

  • Clinical Trial Site

    Cedar Park, Texas · Recruiting

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.